Edmund Dunn Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity
Edmund Dunn is Principal Accounting Officer of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 25,794 shares of GLUE, which is worth approximately $154,506. The most recent transaction as insider was on Jan 02, 2025, when has been sold 11,850 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.8K
84.98%
3M change
n/a
12M change
Total Value Held
$154,506
Edmund Dunn Transaction History
ED
Edmund Dunn
Principal Accounting Officer
Boston, MA